Universal Ibogaine Inc V.IBO

Alternate Symbol(s): IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.

TSXV:IBO - Post by User

Universal Ibogaine Inc

<< Previous

Bullboard Posts

Next >>

Post by MarketGainson Mar 09, 2022 2:19am

138 Views

Post# 34498199

Universal Ibogaine Webcast @ VirtualInvestorConferences.com

Universal Ibogaine Inc. to Webcast Live at OTC Markets VirtualInvestorConferences.com March 10th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

Vancouver B.C., March 08, 2022 — Universal Ibogaine (OTCQB:IBOGF) (TSX-V:IBO) (FSE:JC4), a life sciences company based in Canada, focused on transforming the addiction treatment industry through the medical use of the plant medicine ibogaine, today announced that Nick Karos Name, Chief Executive Officer, will present live at OTC Markets VirtualInvestorConferences.com on March 10^th, 2022.

DATE: March 10^th, 2022
TIME: 12:00 PM EST
LINK:
https://bit.ly/3CjIH4R

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

Event attendees will also be able to schedule 1 on 1 meetings with the Investor Relations team which will take place on Friday March 11, Monday March 14, and Tuesday March 15.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Recent Company Highlights

About Universal Ibogaine

Universal Ibogaine is a life sciences company, with a mission to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a planned Canadian Clinical Trial, and ultimately to utilize that protocol around the globe through future licensing agreements. UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Clinic that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

CONTACTS:

Universal Ibogaine
Dugan Selkirk
Investor Relations Manager
1-855-426-4246
dugan.selkirk@universalibogaine.com

Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com